Minocycline Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Minocycline Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

MINOCYCLINE HYDROCHLORIDE DESCRIPTION



DESCRIPTION


Minocycline Hydrochloride





CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY




MICROBIOLOGY

Microbiology

INDICATIONS AND USAGE


1
1

















1
1


1



1

1




1
1


1

Susceptibility Tests


Dilution techniques


MIC (mcg/mL)Interpretation23
MIC (mcg/mL)Interpretation4
MIC (mcg/mL)Interpretation

MicroorganismMIC Range (mcg/mL)
2
3
4

Diffusion techniques



Zone Diameter (mm)Interpretation5
Zone Diameter (mm)Interpretation6
Zone Diameter (mm)Interpretation7
Zone Diameter (mm)Interpretation8
Zone Diameter (mm)Interpretation

MicroorganismZone Diameter Range (mm)TetracyclineMinocycline
5
6
7
8



INDICATIONS & USAGE

INDICATIONS AND USAGE












































MINOCYCLINE HYDROCHLORIDE CONTRAINDICATIONS

CONTRAINDICATIONS


WARNINGS






DOSAGE AND ADMINISTRATION






PRECAUTIONS

General






INFORMATION FOR PATIENTS

Information For Patients


WARNINGS
Drug Interactions



LABORATORY TESTS

Laboratory Tests



DRUG INTERACTIONS

Drug Interactions





PRECAUTIONS


DRUG & OR LABORATORY TEST INTERACTIONS

Drug/Laboratory Test Interactions


CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY



PREGNANCY

Teratogenic Effects

Pregnancy Category D
WARNINGS


Nonteratogenic Effects
WARNINGS

LABOR & DELIVERY

Labor and Delivery


NURSING MOTHERS

Nursing Mothers
WARNINGS

PEDIATRIC USE

Pediatric Use
WARNINGS

GERIATRIC USE

Geriatric Use
WARNINGSDOSAGE AND ADMINISTRATION


MINOCYCLINE HYDROCHLORIDE ADVERSE REACTIONS



DOSAGE AND ADMINISTRATION

PRECAUTIONS
WARNINGS

WARNINGS



PRECAUTIONS- General

WARNINGS







OVERDOSAGE

OVERDOSAGE




DOSAGE & ADMINISTRATION


CLINICAL PHARMACOLOGY


For Pediatric Patients Above 8 Years Of Age


Adults








WARNINGS

HOW SUPPLIED










STORAGE AND HANDLING





ANIMAL PHARMACOLOGY & OR TOXICOLOGY

ANIMAL PHARMACOLOGY AND TOXICOLOGY


REFERENCES





SPL PATIENT PACKAGE INSERT

PATIENT INFORMATION
MINOCYCLINE HYDROCHLORIDE CAPSULES
50 mg, 75 mg, and 100 mg






ingredients







  • ●     have liver or kidney problems
  • ●     are pregnant or planning to become pregnant. Minocycline hydrochloride capsules may harm your unborn baby. Stop taking minocycline hydrochloride capsules and call your doctor if you become pregnant while taking it.
  • ●     are breast feeding. Minocycline hydrochloride passes into your milk and may harm your baby. You should decide whether to use minocycline hydrochloride capsules or breastfeed, but not both.

  • ●     birth control pills. Minocycline hydrochloride capsules may make your birth control pills less effective
  • ●     a blood thinner medicine. The dose of your blood thinner may have to be lowered.
  • ●     a penicillin antibiotic medicine. Minocycline hydrochloride capsules and penicillins should not be used together.
  • ●     Migraine medicines called ergot alkaloids
  • ●     An acne medicine called isotretinoin
  • ●     Antacids that contain aluminum, calcium, or magnesium, or iron-containing products.


  • ●     Take minocycline hydrochloride capsules exactly as your doctor tells you to take them. Skipping doses or not taking all your minocycline hydrochloride capsules may:




  • ●     Take minocycline hydrochloride capsules with a full glass of liquid. Taking minocycline hydrochloride capsules with enough liquid may lower your chance of getting irritation or ulcers in your esophagus. Your esophagus is the tube that connects your mouth to your stomach.
  • ●     Minocycline hydrochloride capsules may be taken with or without food. If you forget to take minocycline hydrochloride capsules, take it as soon as you remember.
  • ●     If you take too much minocycline hydrochloride capsules, call you doctor or poison control center right away.


  • ●     watery diarrhea
  • ●     bloody stools
  • ●     stomach cramps
  • ●     unusual headaches
  • ●     blurred vision
  • ●     fever
  • ●     rash
  • ●     joint pain
  • ●     feeling very tired

  • ●     central nervous system effects. Symptoms include light-headedness, dizziness, and a spinning feeling (vertigo). You should not drive or operate machines if you have these symptoms.
  • ●     sun sensitivity (photosensitivity). You may get a worse sunburn with minocycline hydrochloride capsules. Avoid sun exposure and the use of sunlamps or tanning beds. Protect your skin while out in the sunlight. Stop minocycline hydrochloride capsules and call your doctor if your skin turns red.


  • ●     Store minocycline hydrochloride capsules at room temperature and away from excess heat and moisture.
  • ●     Throw away any minocycline hydrochloride capsules that are outdated or no longer needed.
  • ●     Keep minocycline hydrochloride capsules and all medicines out of the reach of children.


















INACTIVE INGREDIENT

INACTIVE INGREDIENTS:
LACTOSE MONOHYDRATE

STARCH, CORN
MAGNESIUM STEARATE
TITANIUM DIOXIDE
GELATIN
FERROSOFERRIC OXIDE
FD&C BLUE NO. 1
FERRIC OXIDE YELLOW

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Minocycline Hydrochloride

Minocycline Hydrochloride

Minocycline Hydrochloride

Minocycline Hydrochloride CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-260(NDC:0115-7018)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
MINOCYCLINE HYDROCHLORIDE MINOCYCLINE 100 mg

Inactive Ingredients

Ingredient Name Strength
lactose monohydrate
STARCH, CORN
MAGNESIUM STEARATE
titanium dioxide
GELATIN
FERROSOFERRIC OXIDE
FD&C BLUE NO. 1
FERRIC OXIDE YELLOW

Product Characteristics

Color Size Imprint Code Shape
green 18 mm 0115;7018 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-260-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA065005 2011-03-30


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.